Nu Skin Enterprises, Inc. (NUS) stock
NUSNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 12/3070% below fair value
$3.87+0.09 (+2.38%)
Close on Nov 18, 2026Market cap $188.38MP/E –Yield –
Nu Skin Enterprises operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Nu Skin Enterprises's operating income for the twelve months ending Sep 30, 2026 was -$26.96M. For fiscal 2025 it was $65.76M. Over ten years it grew -12.3% a year on average. The highest annual figure on record is $554.11M in fiscal 2013.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $65.76M | – |
| FY2024 | Dec 31, 2024 | -$151.59M | -414.0% |
| FY2023 | Dec 31, 2023 | $48.27M | -56.5% |
| FY2022 | Dec 31, 2022 | $110.85M | -52.6% |
| FY2021 | Dec 31, 2021 | $233.99M | -9.2% |
| FY2020 | Dec 31, 2020 | $257.56M | -3.7% |
| FY2019 | Dec 31, 2019 | $267.43M | +11.0% |
| FY2018 | Dec 31, 2018 | $240.86M | -12.2% |
| FY2017 | Dec 31, 2017 | $274.48M | +18.8% |
| FY2016 | Dec 31, 2016 | $231.10M | -5.6% |
| FY2015 | Dec 31, 2015 | $244.70M | -30.5% |
| FY2014 | Dec 31, 2014 | $352.19M | -36.4% |
| FY2013 | Dec 31, 2013 | $554.11M | +62.6% |
| FY2012 | Dec 31, 2012 | $340.84M | +45.8% |
| FY2011 | Dec 31, 2011 | $233.74M | +7.7% |
| FY2010 | Dec 31, 2010 | $217.06M | +46.9% |
| FY2009 | Dec 31, 2009 | $147.71M | +17.8% |
| FY2008 | Dec 31, 2008 | $125.43M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $5.09M | -76.5% |
| Q2 FY2026 | Jun 30, 2026 | -$59.32M | -292.7% |
| Q1 FY2026 | Mar 31, 2026 | $4.03M | – |
| Q4 FY2025 | Dec 31, 2025 | $23.24M | – |
| Q3 FY2025 | Sep 30, 2025 | $21.64M | +18.7% |
| Q2 FY2025 | Jun 30, 2025 | $30.78M | – |
| Q1 FY2025 | Mar 31, 2025 | -$9.90M | -212.3% |
| Q4 FY2024 | Dec 31, 2024 | -$53.08M | -430.5% |
| Q3 FY2024 | Sep 30, 2024 | $18.23M | – |
| Q2 FY2024 | Jun 30, 2024 | -$125.56M | -395.4% |
| Q1 FY2024 | Mar 31, 2024 | $8.82M | -45.1% |
| Q4 FY2023 | Dec 31, 2023 | $16.06M | -41.5% |
| Q3 FY2023 | Sep 30, 2023 | -$26.37M | – |
| Q2 FY2023 | Jun 30, 2023 | $42.51M | -17.5% |
| Q1 FY2023 | Mar 31, 2023 | $16.06M | -69.2% |
| Q4 FY2022 | Dec 31, 2022 | $27.46M | +35.1% |
| Q3 FY2022 | Sep 30, 2022 | -$20.28M | -131.0% |
| Q2 FY2022 | Jun 30, 2022 | $51.53M | -39.6% |
| Q1 FY2022 | Mar 31, 2022 | $52.15M | -17.1% |
| Q4 FY2021 | Dec 31, 2021 | $20.32M | -77.1% |
| Q3 FY2021 | Sep 30, 2021 | $65.38M | -11.9% |
| Q2 FY2021 | Jun 30, 2021 | $85.38M | +47.0% |
| Q1 FY2021 | Mar 31, 2021 | $62.91M | +72.1% |
| Q4 FY2020 | Dec 31, 2020 | $88.70M | +62.2% |
| Q3 FY2020 | Sep 30, 2020 | $74.23M | +6.2% |
| Q2 FY2020 | Jun 30, 2020 | $58.07M | -21.7% |
| Q1 FY2020 | Mar 31, 2020 | $36.57M | -46.7% |
| Q4 FY2019 | Dec 31, 2019 | $54.68M | +196.7% |
| Q3 FY2019 | Sep 30, 2019 | $69.89M | -13.4% |
| Q2 FY2019 | Jun 30, 2019 | $74.20M | -10.3% |
| Q1 FY2019 | Mar 31, 2019 | $68.65M | +16.4% |
| Q4 FY2018 | Dec 31, 2018 | $18.43M | -81.4% |
| Q3 FY2018 | Sep 30, 2018 | $80.68M | +25.3% |
| Q2 FY2018 | Jun 30, 2018 | $82.76M | +27.8% |
| Q1 FY2018 | Mar 31, 2018 | $58.99M | +27.5% |
| Q4 FY2017 | Dec 31, 2017 | $99.12M | +63.1% |
| Q3 FY2017 | Sep 30, 2017 | $64.36M | – |
| Q2 FY2017 | Jun 30, 2017 | $64.74M | – |
| Q1 FY2017 | Mar 31, 2017 | $46.26M | – |
| Q4 FY2016 | Dec 31, 2016 | $60.78M | – |
See a number that looks wrong?